One possibility for such observations (in the liver cancer reviewed above) that contradicts the oncogenic role of DDX5 in other cancer types could be that DDX5 has high genome DNA repair capacity in HCC to control HCC malignancy in the defined conditions. The gene discussed is DDX5; the disease is liver cancer.